Pathstone Family Office’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-23,922
Closed -$103K 977
2021
Q4
$103K Buy
+23,922
New +$129K ﹤0.01% 858

Other funds holding CGEN

Pathstone Family Office's CGEN Position: Q1 2022 in Review

Pathstone Family Office sold out of Compugen (CGEN) in Q1 2022, closing a stake of 23,922 shares — an estimated $103K sold.

Pathstone Family Office first reported a position in CGEN in Q4 2021 and held it in 1 quarter. The position peaked at $103K in Q4 2021. 110 funds tracked by Wall St. Rank hold CGEN as of Q1 2022.

  • Pathstone Family Office reported no remaining Compugen position as of Q1 2022 after selling out during the quarter.
  • Pathstone Family Office sold 23,922 Compugen shares in Q1 2022, an estimated $103K.
  • Pathstone Family Office first reported a position in Compugen in Q4 2021 and held it in 1 quarter.
  • Pathstone Family Office's Compugen position peaked at $103K in Q4 2021.
  • 110 funds tracked by Wall St. Rank held Compugen as of Q1 2022.

Based on Pathstone Family Office's 13F filing for Q1 2022, filed 16 May 2022.